Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 26718.14. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 26.51%. Today Baxter International Inc., BAX has gained 0.28%, with a current price of 48.12.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 90.50%. The management of the company have seen the company have a payout ratio of 3.90%. Return of assets are at *TBA, with return on investment at 3.40%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of 47.70%, this is combined with a gross margin of 40.20%, and operating margin of 7.30%. Baxter International Inc. ability to meet debt levels, with a current ratio of *TBA, while the quick ratio is *TBA.
For the last year Baxter International Inc., BAX has seen a EPS growth of -79.90%. A performance for the year of 15.95%. The 52-week high is -1.32%, and the 52-week low is 50.86%. The average volume for Baxter International Inc., BAX is 1081873.
With a target price of 50.25, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 5.54 and a forward P/E of 24.61. Perhaps the more useful indicator than P/E, is PEG which has a value of 0.45. Baxter International Inc. also has a P/S and a P/B of 2.66 and 2.93 respectively. For P/cash, Baxter International Inc. has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 48.12, Baxter International Inc. has a dividend yield of 1.08%. We see a return on equity of *TBA.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 12.22%. In the short-term an EPS growth of 13.04% in the next year is forecasted. This is after a EPS growth of -79.90% for this year and for the last five years a -21.40% growth has been seen.